Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1,978 DKK | -0.80% | -4.33% | -8.24% |
Apr. 16 | Genmab, Johnson & Johnson Logs Higher Q1 Sales for Blood Cancer Drug | MT |
Apr. 16 | Genmab A/S Announces DARZALEX Sales Results for the First Quarter of 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-8.24% | 18.53B | |
-3.30% | 102B | |
+1.79% | 96.07B | |
-1.25% | 21.66B | |
-18.35% | 20.77B | |
-40.31% | 16.91B | |
-26.84% | 13.79B | |
+0.59% | 13.33B | |
+20.86% | 10.94B | |
-21.69% | 8.57B |
- Stock Market
- Equities
- GMAB Stock
- News Genmab A/S
- Genmab A/S : Reports Darzalex Sales of $4.19 Billion in 2020